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Summary. Congenital anaemias due to ineffective erythro-
poiesis may be associated with excessive iron absorption and
progressive iron loading. We investigated whether the
soluble transferrin receptor (TfR) level was related to the
degree of iron overload in 20 patients with thalassaemia
intermedia, six patients with congenital dyserythropoietic
anaemia type II (CDA II) and four patients with X-linked
congenital sideroblastic anaemia (XLSA). All but two
patients had increased serum ferritin levels (median
601 mg/l, range 105±2855 mg/l). Multiple regression analy-
sis showed that 62% (P < 0´0001) of the variation in serum
ferritin was explained by age and by changes in soluble
TfR.
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Congenital anaemias due to ineffective erythropoiesis can be
associated with excessive iron absorption and progressive
iron loading (Finch, 1994). Life-threatening iron overload
may occur in non-transfused patients with thalassaemia
intermedia (Pippard et al, 1979), congenital dyserythropoietic
anaemia type II (CDA II) (Cazzola et al, 1983) and X-linked
congenital sideroblastic anaemia (XLSA) (Cazzola et al,
1983; Peto et al, 1983). The degree of anaemia has been
shown to be a poor predictor of iron loading, which
correlates better with erythroid marrow activity. In fact
studies of erythropoiesis and iron balance in anaemic patients
have shown that expanded erythropoiesis is associated with
increased iron absorption (Pootrakul et al, 1988).
The mechanism by which the erythroid marrow expan-
sion induces a positive iron balance is unknown (Finch,
1994). Recent observations suggest that HFE, an MCH-
related protein which is mutated in genetic haemochroma-
tosis (Feder et al, 1996), may regulate iron homeostasis by
interacting with transferrin receptor (TfR). HFE protein, in
fact, binds to TfR with high af®nity and decreases binding of
diferric transferrin (Feder et al, 1998). In addition, soluble
TfR and HFE bind tightly at the basic pH of the cell surface,
but not at the acidic pH of intracellular vesicles (Lebron et al,
1998).
A soluble form of TfR, probably representing a truncated
form of tissue receptor, is present in human plasma (Huebers
et al, 1990). The erythroid marrow is its main source and the
soluble TfR concentration is increased in conditions with
erythroid hyperplasia. We investigated whether the level of
soluble TfR was related to the degree of iron overload in a
group of patients with congenital anaemia due to ineffective
erythropoiesis.
PATIENTS AND METHODS
We studied 20 patients with thalassaemia intermedia, six
patients with CDA II and four patients with XLSA who had
received no or only occasional blood transfusions; their
ages ranged from 7 to 66 years. The 20 patients with
thalassaemia intermedia were followed at the Haematology
Department of the Istituto di Clinica e Biologia dell'EtaÁ
Evolutiva, University of Cagliari, Sardinia, Italy. All were of
Sardinian descent and ful®lled accepted criteria for a
diagnosis of thalassaemia intermedia. The six patients with
CDA II and the four males with XLSA were followed at the
Department of Internal Medicine and Medical Therapy,
University of Pavia Medical School and IRCCS Policlinico
S. Matteo, Pavia, Italy. Diagnosis of CDA II was based on
British Journal of Haematology, 1999, 106, 752±755
752 q 1999 Blackwell Science Ltd
Correspondence: Professor Mario Cazzola, Internal Medicine and
Medical Oncology, IRCCS Policlinico S. Matteo, 27100 Pavia, Italy.
e-mail: m.cazzola@iol.it.
the following criteria: (a) presence of > 10% binucleated
erythroblasts in the bone marrow; (b) positivity of acidi®ed
serum test with some normal sera and negativity with
patient's own serum. Patients with XLSA had a microcytic
congenital anaemia associated with the presence of ringed
sideroblasts in the bone marrow. In all of them, missense
mutations in the erythroid-speci®c ALA synthase gene
(ALAS2) were demonstrated (unpublished observations).
Informed consent was obtained from each subject or from
the parents of patients under the age of 18 to draw blood for
the study while they were under routine care. Blood counts
were obtained with a Coulter Counter Model S. Body iron
status was assessed by estimation of serum ferritin through a
radioimmunoassay method (Ramco Lab, Houston, Texas,
U.S.A.). Circulating erythropoietin levels were measured by a
radioimmunoassay method (Incstar Corp., Sillwater, Min.,
U.S.A.) that utilizes recombinant human erythropoietin for
tracer and standards.
The amount of serum TfR was estimated by an enzyme-
linked polyclonal antibody assay, using puri®ed placental
receptor±transferrin complexes as a reference standard and
rabbit antibodies. TfR levels in 165 normal control subjects
were 5´0 6 1´1 mg/l, with 95% con®dence limits ranging
from 2´9 to 7´1 mg/l.
For molecular characterization of thalassaemia defects,
DNA was extracted from peripheral blood leucocytes, and
a-globin genotype determination and b-thalassaemia defect
characterization were performed.
For PCR-RFLP detection of the two HFE mutations (C282Y
and H63D) separate PCR reactions were conducted for the
two mutations using the primers described by Feder et al
(1996). Restriction digests were performed directly in the
PCR mixes by addition of 5 U Rsa I (codon 282 reactions) or
Bcl I (codon 63 reactions) and incubating for 2 h at 378C or
508C, respectively. The products were electrophoresed on a
2% agarose gel.
As control populations, we selected 30 normal subjects
and 30 b8-thalassaemia heterozygotes with low haemo-
globin (Hb) levels, well matched with respect to sex and
age. Heterozygous b-thalassaemia was chosen as an anaemic
condition that generally is not associated with iron loading.
Data were stored, analysed and reported with the
packages STATISTICA/Mac (StatSoftTM, Tulsa, Okla.),
ExstatixTM (Select Micro Systems Inc., Yorktown Heights,
N.Y.) and DeltaGraphTM Pro 3 (DeltaPoint Inc., Monterey,
Calif.), all run on a Macintosh Quadra 650 (Apple Computer
Inc., Cupertino, Calif.) personal computer. Results were
expressed as mean 6 1 standard deviation (SD) unless
otherwise stated. The Student's t-test and/or the F test
(analysis of variance) were used to evaluate the probability of
any signi®cant difference between groups. Multiple regres-
sion analysis was employed to identify the parameters more
closely related to serum ferritin. P values < 0´05 were
considered to be statistically signi®cant.
RESULTS
The main haematological ®ndings are summarized in Table I.
The degree of anaemia was highly variable, with the Hb
ranging from 6´6 to 12´5 g/dl in the patient population.
Soluble TfR levels ranged from 3 to 12 times normal and
were inversely related to Hb levels, although the level of
signi®cance was borderline (P0´05). Serum erythropoie-
tin values ranged from 40 to 1600 U/l and were inversely
related to Hb levels (r0´52, F11´99, P0´0017).
All but two subjects had increased serum ferritin levels
and 7/10 individuals aged > 30 years had clinical signs of
parenchymal organ dysfunction. The proportion of indivi-
duals aged > 30 years with evidence of organ dysfunction
was signi®cantly higher than that of those aged < 30
(x2 9´07, P0´0026).
Univariate regression analysis was ®rst performed to
identify the parameters more closely related to serum
ferritin. As judged by serum ferritin levels, iron loading
occurred regardless of the degree of anaemia and also
showed no relationship with sex, basic disease and serum
erythropoietin. 15/30 patients had never been transfused
and the remaining 15 had received only occasional
transfusions (< 12 and < 0´5 per year in any case).
Regression analysis showed no relationship between serum
ferritin and the number of RBC transfusions received. 8/30
patients (27%) were heterozygous for the HFE H63D
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Patients and controls Hb (g/dl) (mg/l) (U/l) (mg/l)
Iron-loading anaemias (n30) 9´0 6 1´5 957 6 792 425 6 429 39´0 6 11´5
(6´6±12´5) (105±2855) (40±1600) (15´8±58´7)
Heterozygous b-thalassaemia (n30) 10´4 6 0´8 82 6 72 19 6 9 6´7 6 1´7
(9´0±12´0) (15±264) (6±45) (4´0±10´9)
Normal control subjects (n30) 14´4 6 1´3 69 6 45 16 6 5 5´3 6 1´0
(12´5±16´8) (25±178) (8±30) (3´7±7´5)
Numbers are mean 6 1 SD with the range in parentheses.
mutation, whereas only one was heterozygous for the HFE
C282Y mutation; there was no relationship between HFE
mutations and serum ferritin.
Age and soluble TfR were the only two factors related to
iron load in univariate regression analysis. In fact, as judged
by serum ferritin, iron load was closely related to the
patient's age (P < 0´0001) and the soluble TfR level
(P0´0002). Serum ferritin values in excess of 1000 mg/l
were found only in patients with soluble TfR levels > 30 mg/l,
i.e. > 6 times normal.
Multiple regression analysis showed that 62%
(P < 0´0001) of the variation in serum ferritin was explained
by age (representing the length of time of exposure to the
risk) and by changes in soluble TfR (the putative determinant
of iron loading). As expected, there was a close relationship
between the serum ferritin concentration and the product of
the above two parameters (Fig 1).
The 30 subjects with heterozygous b-thalassaemia had Hb
levels ranging from 9 to 12 g/dl (Table I), markedly lower
than those of normal control subjects (F215´08, P <
0´0001). There was no associated congenital or acquired
condition that could explain the low Hb levels of these
individuals. In particular, the following conditions were
excluded in each case: excess of alpha genes, haemoglobino-
pathies or disorders of the red cell membrane, iron de®ciency,
folate or vitamin B12 de®ciency, Soluble TfR levels of these
anaemic subjects with heterozygous b-thalassaemia were
only slightly higher than those of normal controls (6´7 6 1´7
v 5´3 6 1´0 mg/l, F13´85, P0´0004). There was no
difference between b-thalassaemia heterozygotes and normal
individuals with respect to serum ferritin levels (P0´39).
DISCUSSION
Iron-loading anaemias are primarily characterized by very
high degrees of erythroid proliferation that involve parallel
increases in iron exchange. In fact, whereas the normal
erythroid iron turnover is about 30 mg/d, as much as
300 mg of iron per day may be required in individuals with
expanded erythropoiesis. The increased erythron require-
ment has important effects on the reticuloendothelial cells
and intestinal mucosa. Reticuloendothelial cells return a far
greater proportion of processed iron than is normally
released to transferrin, although they also hold an increased
amount of iron. At the same time there is a parallel increase
in iron absorption (Pootrakul et al, 1988), and the amount of
iron absorbed exceeds the body iron losses, so that there is a
progressive parenchymal iron loading.
Experimental and clinical evidence suggests that the
erythron-induced increase in iron absorption is in some way
related to erythropoiesis (Finch, 1994), although different
anaemic states differ in the magnitude of the absorptive
response. In fact, iron loading is generally more severe in
patients with anaemia due to ineffective erythropoiesis than
in haemolytic states (Pootrakul et al, 1988).
Clearly some components of erythroid marrow must
mediate the message between expanded erythropoiesis and
increased intestinal iron absorption. It has been previously
proposed that the transferrin receptor mass of the bone
marrow is the regulator and transferrin the mediator of the
message (Finch, 1994). When extremely high rates of
erythropoiesis are required, transferrin receptor needs are
not met and increased absorption results. It is this state of
receptor unsaturation which appears to result in progressive
iron loading.
Transferrin receptor density on erythroid cells is regulated
by several factors, the most important ones being cellular
iron status and erythropoietin stimulation. Both deprivation
of iron and erythropoietin stimulation increase the number
of receptors (Weiss et al, 1997). Soluble TfR is a truncated
form of tissue receptor (Shih et al, 1990) whose generation is
probably due to a proteolytic mechanism. The erythroid
marrow is the main source of soluble transferrin receptors
and increased levels are found in erythroid hyperplasia
(Huebers et al, 1990). Evidence has been provided that
unsaturation of transferrin receptors on erythroid cells
enhances generation of soluble TfR (Baynes, 1995). All
these observations suggest that anaemias associated with
expanded but ineffective erythropoiesis involve the presence
of large amounts of TfR on erythroid cells and the production
of large amounts of soluble receptor.
Recent studies have reported evidence of a physical
interaction between HFE and TfR (Feder et al, 1998;
Lebron et al, 1998). This interaction appears to result in
inhibition of iron absorption, although the underlying
mechanisms are not known. In the context of our current
understanding of HFE/TfR interactions, the ®ndings of the
present study suggest that high-soluble TfR levels may
contribute to impairing regulation of iron homeostasis and
determining progressive iron loading in patients with
congenital anaemias. Our working hypothesis is that soluble
TfR inactivates the inhibitory effect of HFE protein on
intestinal iron absorption. This is in keeping with the
observation that iron absorption is increased both in iron
de®ciency and in iron-loading anaemias, i.e. two contrasting
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Fig 1. Relationship between the product of the patient's age times the
soluble TfR level at the time of study and the serum ferritin
concentration. Regression analysis provided the following results:
serum ferritin (mg/l)ÿ1205 (41´2 ´ age, yr) (26´5 ´ soluble
TfR, mg/l) (multiple-R0´788, F24´783, P < 0´0001).
conditions whose only common denominator is a high level
of soluble TfR. On the other hand, it is also in keeping with
the observation that anaemic individuals with heterozygous
b-thalassaemia had only marginally elevated soluble TfR
levels and nearly normal serum ferritin concentrations.
Based on the data presented in this paper we cannot rule
out that soluble TfR may simply represent an indirect
indicator of erythroid activity, which is already known to be
somehow associated with increased iron absorption. From a
clinical point of view, however, the measurement of soluble
TfR may be useful in predicting the risk of iron overload in
individual patients with congenital anaemia with ineffective
erythropoiesis. Our ®ndings suggest that values steadily in
excess of 5±6 times normal are associated with a high risk of
iron overload in middle age.
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